1. From the Department of Adult Oncology, Dana Farber Cancer Institute; and Department of Medicine, Harvard Medical School, Boston, MA; Bayer Diagnostics, Walpole, MA; Academic Hospital, Vrije Universiteit, Amsterdam, The Netherlands; and Department of Medical Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada.